Btk expression is controlled by Oct and BOB.1/OBF.1

被引:18
作者
Brunner, C [1 ]
Wirth, T [1 ]
机构
[1] Univ Ulm, Dept Physiol Chem, D-89091 Ulm, Germany
关键词
D O I
10.1093/nar/gkl131
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BOB.1/OBF.1 is a lymphocyte-restricted transcriptional coactivator. It binds together with the Oct1 and Oct2 transcription factors to DNA and enhances their transactivation potential. Mice deficient for the transcriptional coactivator BOB.1/OBF.1 show several defects in differentiation, function and signaling of B cells. In search of BOB.1/OBF.1 regulated genes we identified Btk-a cytoplasmic tyrosine kinase-as a direct target of BOB.1/OBF.1. Analyses of the human as well as murine Btk promoters revealed a non-consensus octamer site close to the start site of transcription. Here we show that Oct proteins together with BOB.1/OBF.1 are able to form ternary complexes on these sites in vitro and in vivo. This in turn leads to the induction of Btk promoter activity in synergism with the transcription factor PU.1. Btk, like BOB.1/OBF.1, plays a critical role in B cell development and B cell receptor signalling. Therefore the down-regulation of Btk expression in BOB.1/OBF.1-deficient B cells could be related to the functional and developmental defects observed in BOB.1/OBF.1-deficient mice.
引用
收藏
页码:1807 / 1815
页数:9
相关论文
共 64 条
[1]   OCT2 TRANSACTIVATION FROM A REMOTE ENHANCER POSITION REQUIRES A B-CELL-RESTRICTED ACTIVITY [J].
ANNWEILER, A ;
MULLERIMMERGLUCK, M ;
WIRTH, T .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (07) :3107-3116
[2]   OCA-B is a functional analog of VP16 but targets a separate surface of the Oct-1 POU domain [J].
Babb, R ;
Cleary, MA ;
Herr, W .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (12) :7295-7305
[3]   Bruton's tyrosine kinase links the B cell receptor to nuclear factor κB activation [J].
Bajpai, UD ;
Zhang, KM ;
Teutsch, M ;
Sen, R ;
Wortis, HH .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (10) :1735-1744
[4]   New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2 [J].
Botquin, V ;
Hess, H ;
Fuhrmann, G ;
Anastassiadis, C ;
Gross, MK ;
Vriend, G ;
Schöler, HR .
GENES & DEVELOPMENT, 1998, 12 (13) :2073-2090
[5]  
Brunner C, 2005, HISTOL HISTOPATHOL, V20, P945, DOI 10.14670/HH-20.945
[6]   Expression of the aldehyde dehydrogenase 2-like gene is controlled by BOB.1/OBF.1 in B lymphocytes [J].
Brunner, C ;
Laumen, H ;
Nielsen, PJ ;
Kraut, N ;
Wirth, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (46) :45231-45239
[7]   B cell-specific transgenic expression of Bcl2 rescues early B lymphopoiesis but not B cell responses in BOB.1/OBF.1-deficient mice [J].
Brunner, C ;
Marinkovic, D ;
Klein, J ;
Samardzic, T ;
Nitschke, L ;
Wirth, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (09) :1205-1211
[8]   Sequence-specific DNA binding of the B-cell-specific coactivator OCA-B [J].
Cepek, KL ;
Chasman, DI ;
Sharp, PA .
GENES & DEVELOPMENT, 1996, 10 (16) :2079-2088
[9]   Crystal structure of an OCA-B peptide bound to an Oct-1 POU domain/octamer DNA complex: specific recognition of a protein-DNA interface [J].
Chasman, D ;
Cepek, K ;
Sharp, PA ;
Pabo, CO .
GENES & DEVELOPMENT, 1999, 13 (20) :2650-2657
[10]  
CHRISTENSEN SM, 1992, J IMMUNOL, V148, P3610